Skip to main content
. 2020 May 18;11(15):4534–4541. doi: 10.7150/jca.39410

Figure 1.

Figure 1

PFS and OS of ICC patients underwent DEB-TACE with CSM. The median PFS(A) and OS(B) were 3.0 months and 9.0 months respectively in ICC patients underwent DEB-TACE with CSM treatment. Kaplan-Meier curve was used to evaluate PFS and OS in ICC patients. PFS, progression-free survival; OS, overall survival; ICC intrahepatic cholangiocarcinoma.